Analyst Ratings for Altimmune (ALT)
ALT Rating Summary
ALT Price Target Summary
- Highest: $28.00 (Jefferies)
- Lowest: $2.50 (Goldman Sachs)
- Average: $16.50
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$16.50 (+511.1%)
* Over Last 12-Mos
Rating Score: 8 / 10
Percentile Rank: 83%
Avg. $ Target:
$16.50 (+511.1%)
* Over Last 12-Mos
Rating Score: 8 / 10
Percentile Rank: 83%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/24/2026 | Goldman Sachs | Corinne Johnson | Upgrade | Neutral (Sell) |
2.50 (N/A) |
2.89 (2.70) |
-6.57% | Details |
| 3/18/2026 | Truist Securities | Srikripa Devarakonda | New Coverage | Buy (N/A) |
12.00 (N/A) |
3.53 (2.70) |
-23.51% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
